These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3292144)

  • 1. Blood pressure changes during treatment with recombinant human erythropoietin.
    Samtleben W; Baldamus CA; Bommer J; Fassbinder W; Nonnast-Daniel B; Gurland HJ
    Contrib Nephrol; 1988; 66():114-22. PubMed ID: 3292144
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
    Grützmacher P; Bergmann M; Weinreich T; Nattermann U; Reimers E; Pollok M
    Contrib Nephrol; 1988; 66():104-13. PubMed ID: 3292143
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
    Baldamus CA; Steffen AM; Brunner R; Pollok M
    Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
    [No Abstract]   [Full Text] [Related]  

  • 6. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP; Benz RL; Sigler MH; Brown JM
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function.
    Grützmacher P; Scheuermann E; Löw I; Bergmann M; Rauber K; Baum R; Heuser J; Schoeppe W
    Contrib Nephrol; 1988; 66():176-84. PubMed ID: 3292146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Revolution in the treatment of chronic renal insufficiency anemia: the role of recombinant erythropoietin].
    Panas N; Turkowa M; Zgheib A; Krzesinski JM; Rorive G
    Rev Med Liege; 1990 Jun; 45(6):280-5. PubMed ID: 2367758
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human erythropoietin in predialysis patients.
    Lim VS
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):34-7. PubMed ID: 1928077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R; Hand M
    N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
    Bommer J; Huber W; Tewes G; Ritz E; von Wedel S; Küppers S; Weinreich T; Bommer G
    Contrib Nephrol; 1988; 66():131-8. PubMed ID: 3391027
    [No Abstract]   [Full Text] [Related]  

  • 14. Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin.
    Zehnter E; Pollok M; Ziegenhagen D; Bramsiepe P; Longere F; Baldamus CA; Wellner U; Waters W
    Contrib Nephrol; 1988; 66():149-55. PubMed ID: 3391029
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of renal anaemia by recombinant human erythropoietin.
    Stifter S; Graf H
    Pol Arch Med Wewn; 1991 Jun; 85(6):329-33. PubMed ID: 1896395
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation.
    Nonnast-Daniel B; Creutzig A; Kühn K; Bahlmann J; Reimers E; Brunkhorst R; Caspary L; Koch KM
    Contrib Nephrol; 1988; 66():185-94. PubMed ID: 3292147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 18. Side effects of erythropoietin therapy.
    Bennett WM
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):84-6. PubMed ID: 1928085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin 1991--biology, clinical use, and impact on patients: an international symposium. February 8-9, 1991, Nashville, Tennessee.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):1-116. PubMed ID: 1681726
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin.
    Pfåffl W; Gross HJ; Neumeier D; Nattermann U; Samtleben W; Gurland HJ
    Contrib Nephrol; 1988; 66():195-204. PubMed ID: 3391032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.